GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Total Payout Yield %

Longevity Biomedical (Longevity Biomedical) Total Payout Yield % : 0.00 (As of May. 17, 2024)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Longevity Biomedical's current Total Payout Yield % is 0.00%.


Longevity Biomedical Total Payout Yield % Historical Data

The historical data trend for Longevity Biomedical's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Total Payout Yield % Chart

Longevity Biomedical Annual Data
Trend
Total Payout Yield %

Longevity Biomedical Semi-Annual Data
Total Payout Yield %

Competitive Comparison of Longevity Biomedical's Total Payout Yield %

For the Biotechnology subindustry, Longevity Biomedical's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Total Payout Yield % falls into.



Longevity Biomedical Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Longevity Biomedical's Total Payout Yield % for the fiscal year that ended in . 20 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- ( + + ) /
=N/A%

Longevity Biomedical's annualized Total Payout Yield % for the quarter that ended in . 20 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- ( + + ) * 1 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longevity Biomedical Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Longevity Biomedical Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines